PXS.AX - Pharmaxis Ltd

ASX - ASX Delayed Price. Currency in AUD
Currency in AUD

Valuation Measures

Market Cap (intraday) 583.13M
Enterprise Value 369.12M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)9.41
Price/Book (mrq)23.64
Enterprise Value/Revenue 37.82
Enterprise Value/EBITDA 6-4.34

Financial Highlights

Fiscal Year
Fiscal Year Ends Jun 30, 2017
Most Recent Quarter (mrq)Jun 30, 2017
Profit Margin -207.65%
Operating Margin (ttm)-217.40%
Management Effectiveness
Return on Assets (ttm)-21.61%
Return on Equity (ttm)-150.09%
Income Statement
Revenue (ttm)8.84M
Revenue Per Share (ttm)0.03
Quarterly Revenue Growth (yoy)28.00%
Gross Profit (ttm)8M
EBITDA -15.94M
Net Income Avi to Common (ttm)-18.35M
Diluted EPS (ttm)-0.06
Quarterly Earnings Growth (yoy)N/A
Balance Sheet
Total Cash (mrq)21.5M
Total Cash Per Share (mrq)0.07
Total Debt (mrq)9.25M
Total Debt/Equity (mrq)262.74
Current Ratio (mrq)2.72
Book Value Per Share (mrq)0.01
Cash Flow Statement
Operating Cash Flow (ttm)-15.26M
Levered Free Cash Flow (ttm)-9.42M

Trading Information

Stock Price History
Beta N/A
52-Week Change 30.00%
S&P500 52-Week Change 317.34%
52 Week High 30.31
52 Week Low 30.23
50-Day Moving Average 30.26
200-Day Moving Average 30.26
Share Statistics
Avg Vol (3 month) 3210.09k
Avg Vol (10 day) 3144.68k
Shares Outstanding 5319.72M
Float 228.96M
% Held by Insiders 1N/A
% Held by Institutions 1N/A
Shares Short 3N/A
Short Ratio 3N/A
Short % of Float 3N/A
Shares Short (prior month) 3N/A
Dividends & Splits
Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 4N/A
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A